Optimism in US biotech wiped away by global fears catalysed by Dendreon implosion
This article was originally published in Scrip
Executive Summary
US stocks took a nose dive 4 August, as investors dumped stocks amidst anxiety that global economic strains were worsening and policy makers have been failing to stabilise the situation. Biotech stocks posted particularly steep losses, dragging the NASDAQ Biotech Index down 13% between 1 August and 5 August. ISI Group analyst Joe Ruggieri called the 4 August slump the worst one-day loss since March 2000, ironically six days after Dendreon filed its initial public offering.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.